GlassScriptPhysician profile
Joseph Li-Han Yang
NPI 1003115486
$1,583.03
in general payments reported to CMS, 2019-2025
14 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $142 · 2021: $318 · 2022: $36.55 · 2023: $188 · 2024: $97.55 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $450.24 | 2019-2024 | Comet, Rotapro |
| Abbott Laboratories | $278.21 | 2021-2023 | Mitraclip |
| Edwards Lifesciences Corporation | $260.80 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $237.61 | 2019-2020 | |
| Medtronic Vascular, INC. | $97.94 | 2019 | |
| Medtronic, INC. | $51.89 | 2025 | Symplicity G3 |
| Cardiovascular Systems INC. | $47.20 | 2019 | |
| Inari Medical, INC. | $45.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $37.64 | 2023 | Angio-Seal |
| Asahi Intecc USA, INC. | $24.22 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.71 | 2019 | |
| Ekos Corporation | $15.58 | 2019 | |
| Medline Industries LP | $12.69 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.